PRESCIENT NEUROPHARMA INC. TRANSFERS TO NEX

TSXV: PNO.H

VANCOUVER, Jan. 27 /CNW/ - Prescient Neuropharma Inc. (the "Company") has been advised by the TSX Venture Exchange that its listing will be transferred to the NEX board and its shares will trade under the symbol PNO.H effective at the opening January 28, 2011. The Company is continuing with its search for significant assets in the natural resource sector in conjunction with its financial advisor Endeavour Financial Ltd.

ON BEHALF OF THE BOARD OF DIRECTORS

  "Gordon Keep"
Per:  
  Gordon Keep
  President & Director

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE

SOURCE Prescient NeuroPharma Inc.

For further information:

Gordon Keep
President & Director
Tel:  (604) 609-6110

Organization Profile

Prescient NeuroPharma Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890